Advertisement

Research Article Free access | 10.1172/JCI110380

Reactivity of a monoclonal antibody with human ovarian carcinoma.

R C Bast Jr, M Feeney, H Lazarus, L M Nadler, R B Colvin, and R C Knapp

Find articles by Bast, R. in: JCI | PubMed | Google Scholar

Find articles by Feeney, M. in: JCI | PubMed | Google Scholar

Find articles by Lazarus, H. in: JCI | PubMed | Google Scholar

Find articles by Nadler, L. in: JCI | PubMed | Google Scholar

Find articles by Colvin, R. in: JCI | PubMed | Google Scholar

Find articles by Knapp, R. in: JCI | PubMed | Google Scholar

First published November 1, 1981 - More info

Published in Volume 68, Issue 5 on November 1, 1981
J Clin Invest. 1981;68(5):1331–1337. https://doi.org/10.1172/JCI110380.
© 1981 The American Society for Clinical Investigation
First published November 1, 1981 - Version history
Abstract

A murine monoclonal antibody (OC125) has been developed that reacts with each of six epithelial ovarian carcinoma cell lines and with cryopreserved tumor tissue from 12 of 20 ovarian cancer patients. By contrast, the antibody does not bind to a variety of nonmalignant tissues, including adult and fetal ovary. OC125 reacts with only 1 of 14 cell lines derived from nonovarian neoplasms and has failed to react with cryostat sections from 12 nonovarian carcinomas.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (November 1, 1981): No description
Advertisement
Advertisement